Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25899 | 222 | 33.3 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
339 | 17217 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GI ALPHA PROTEINS | Author keyword | 2 | 67% | 1% | 2 |
2 | GI ALPHA PROTEIN | Author keyword | 1 | 100% | 1% | 2 |
3 | GQALPHA PROTEIN | Author keyword | 1 | 100% | 1% | 2 |
4 | MILAN RAT | Author keyword | 1 | 100% | 1% | 2 |
5 | GRP RECH SYST NERVEUX AUTONOME | Address | 1 | 11% | 4% | 9 |
6 | A10 SMOOTH MUSCLE CELLS | Author keyword | 1 | 40% | 1% | 2 |
7 | GRP RECH SYST NERVEUX AUTON | Address | 1 | 40% | 1% | 2 |
8 | GI PROTEINS | Author keyword | 1 | 13% | 3% | 7 |
9 | GRSNA | Address | 1 | 33% | 1% | 2 |
10 | ADERYLYL CYCLASE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GI ALPHA PROTEINS | 2 | 67% | 1% | 2 | Search GI+ALPHA+PROTEINS | Search GI+ALPHA+PROTEINS |
2 | GI ALPHA PROTEIN | 1 | 100% | 1% | 2 | Search GI+ALPHA+PROTEIN | Search GI+ALPHA+PROTEIN |
3 | GQALPHA PROTEIN | 1 | 100% | 1% | 2 | Search GQALPHA+PROTEIN | Search GQALPHA+PROTEIN |
4 | MILAN RAT | 1 | 100% | 1% | 2 | Search MILAN+RAT | Search MILAN+RAT |
5 | A10 SMOOTH MUSCLE CELLS | 1 | 40% | 1% | 2 | Search A10+SMOOTH+MUSCLE+CELLS | Search A10+SMOOTH+MUSCLE+CELLS |
6 | GI PROTEINS | 1 | 13% | 3% | 7 | Search GI+PROTEINS | Search GI+PROTEINS |
7 | ADERYLYL CYCLASE | 1 | 50% | 0% | 1 | Search ADERYLYL+CYCLASE | Search ADERYLYL+CYCLASE |
8 | CELL RESETTING | 1 | 50% | 0% | 1 | Search CELL+RESETTING | Search CELL+RESETTING |
9 | GALPHA I2 | 1 | 50% | 0% | 1 | Search GALPHA+I2 | Search GALPHA+I2 |
10 | GIALPHA PROTEIN | 1 | 50% | 0% | 1 | Search GIALPHA+PROTEIN | Search GIALPHA+PROTEIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MYOCARDIAL SARCOLEMMA | 7 | 57% | 4% | 8 |
2 | NATRIURETIC FACTOR RECEPTORS | 5 | 60% | 3% | 6 |
3 | NUCLEOTIDE REGULATORY PROTEIN | 5 | 14% | 14% | 32 |
4 | ANP C RECEPTOR | 4 | 75% | 1% | 3 |
5 | MYOCARDIAL ADENYLATE CYCLASE | 3 | 57% | 2% | 4 |
6 | GI ALPHA PROTEINS | 2 | 50% | 1% | 3 |
7 | ANTIMIGRATION | 1 | 50% | 0% | 1 |
8 | ENDOTHELIAL GI PROTEIN | 1 | 50% | 0% | 1 |
9 | INDUCED CAMP | 1 | 50% | 0% | 1 |
10 | GI PROTEIN | 1 | 14% | 2% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Impaired vasodilator function in hypertension - The role of alterations in receptor-G protein coupling | 1998 | 40 | 103 | 32% |
Impaired Control of L-Type Voltage-Dependent Calcium Channels in Experimental Hypertension | 2009 | 7 | 38 | 8% |
Targeted, regulatable expression of activated heterotrimeric G protein alpha subunits in transgenic mice | 2002 | 0 | 7 | 29% |
THE MAIN STAGES AND WAYS OF LIPOLYSIS REGULATION - CHARACTERISTICS OBSERVED IN HYPERTENSION | 1981 | 0 | 3 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP RECH SYST NERVEUX AUTONOME | 1 | 11% | 4.1% | 9 |
2 | GRP RECH SYST NERVEUX AUTON | 1 | 40% | 0.9% | 2 |
3 | GRSNA | 1 | 33% | 0.9% | 2 |
4 | CENTRUM EXCELLENCE CARDIOVASC | 1 | 50% | 0.5% | 1 |
5 | PHYSIOPATHOL HORMONE ACT | 1 | 50% | 0.5% | 1 |
6 | TRANSGEN MICE IL | 1 | 50% | 0.5% | 1 |
7 | UNIT 489 | 1 | 50% | 0.5% | 1 |
8 | UP EA 3116 | 0 | 33% | 0.5% | 1 |
9 | PEDIAT SURG SECT SURG | 0 | 25% | 0.5% | 1 |
10 | CLIN PHARMACOL PHARMACOL | 0 | 17% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195715 | MEMBRANE LIPID THERAPY//MOL CELL BIOMED//MOL CELLULAR BIOMED |
2 | 0.0000171743 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
3 | 0.0000161925 | BIOCHEM MEMBRANE RECEPTORS GRP//MEMBRANE RECEPTORS//TRIMERIC G PROTEINS |
4 | 0.0000146865 | STRUCTURAL VASCULAR CHANGES//SMOOTH MUSCLE PROGRAMME//VASCULAR HYPERTROPHY |
5 | 0.0000141899 | ADENYLYL CYCLASE SYSTEM//ADENYLYL CYCLASE MECHANISM//INSULIN SUPERFAMILY PEPTIDES |
6 | 0.0000137145 | ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR |
7 | 0.0000124683 | GPRC5A//GNAS1//CELLULAR SIGNALINGCANC |
8 | 0.0000105355 | CAROTID GLOMUS//GUANADREL//CATECHOLAMINERGIC LESIONS |
9 | 0.0000103325 | AFFERENT RENAL NERVES//AFFERENT RENAL NERVE ACTIVITY//RENAL CHEMORECEPTORS |
10 | 0.0000102480 | NONMODULATION//HYPERTENSION NONMODULATING//EXTREME NORTH |